A long-term follow-up of clinical response and regional cerebral blood flow changes in depressed patients treated with ECT.

Summary, in English

Depression is the leading cause of disability worldwide and electroconvulsive therapy (ECT) is the most potent therapy. We investigated the clinical response and regional cerebral blood flow changes in depressed in patients treated with (ECT) in a repeated longitudinal study. Method: Forty-nine patients (21 men and 28 women) with a mean age 61 years underwent ECT. Forty-one patients grading improvement after the initial ECT-series (responder group) were compared with eight, grading no improvement (non-responder group). The patients underwent neuropsychiatric ratings, measure of clinical response (defined as≥50% reduction of pre-treatment depression score) and measure of regional cerebral blood flow (rCBF).

• Author: Ake Berggren; Lars Gustafson; Peter Höglund; Aki Johanson
• Department/s: Psychiatry (Lund); Division of Clinical Chemistry and Pharmacology
• Publishing year: 2014
• Language: English
• Pages: 235-243
• Publication/Series: Journal of Affective Disorders
• Volume: 167
• Issue: Jun 12
• Links: http://www.ncbi.nlm.nih.gov/pubmed/24997226?dopt=Abstract; http://dx.doi.org/10.1016/j.jad.2014.06.005
• Document type: Journal article
• Publisher: Elsevier
• Topic: Psychiatry
• Status: Published
• ISBN/ISSN/Other: ISSN: 1573-2517